PAR paradigm biopharmaceuticals limited..

Thanks, Mozz, your "technical"posts are always especially...

  1. 5 Posts.
    lightbulb Created with Sketch. 2
    Thanks, Mozz, your "technical"posts are always especially informative. Two little queries however. You have "always" assumed that the p-values from the 008 study will improve dramatically in any subsequent study involving a larger number of participants. Probably, hopefully, this will turn out to be the case but you seem to assume that this is nearly axiomatic. Presumably a larger study is more reliable, but this implies that the initial smaller study is less reliable, which suggests we should be careful not to put so much weight on such a study. Also, is it wise to jump from an effect on canines after 26 weeks to so confidently assume a similar effect on humans after 3 years. That seems to be a stretch for me. Again, thanks for your research which I am sure is invaluable for most of us.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
34.5¢
Change
-0.010(2.82%)
Mkt cap ! $137.1M
Open High Low Value Volume
36.0¢ 36.0¢ 33.8¢ $249.3K 726.6K

Buyers (Bids)

No. Vol. Price($)
2 4558 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 8581 1
View Market Depth
Last trade - 16.10pm 01/08/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.